{
  "compound": "Cannabinoids (dronabinol)",
  "condition": "ALZHEIMERS",
  "effect_size": "Promising signals",
  "study_type": "SYSTEMATIC_REVIEW",
  "source": "NORML:ALZHEIMERS_SYSTEMATIC_REVIEW_001",
  "participants": "Limited studies at time of review",
  "year": 2009,
  "notes": "Cannabinoids for Dementia: Cochrane Systematic Review",
  "confidence": "medium",
  "abstract": "Insufficient evidence for firm conclusions; dronabinol shows promise for behavioral symptoms; more RCTs needed"
}